Genartis Srl

Genartis is an innovative start-up born in 2019 and now being accredited as a spin-off of the University of Verona. Genartis offers highly technological services in the field of personalized genomics and DNA sequencing. By exploiting innovative genomic technologies such as long-read-sequencing and genome editing by CRISPR-Cas9, the mission of Genartis is to provide novel genetic tests that overcome the limits of assays currently available on the market and “fill their gaps", thus providing sure answers. The novel genomic technologies offered by Genartis provide several advantages in different field of application, ranging from personalized medicine, agricultural genomics, microbiology, ecology to basic research.